MUMBAI, India, July 31 -- Intellectual Property India has published a patent application (202411096009 A) filed by Lovely Professional University on December 05, 2024, for Mitochondrial Gene Therapy For Mt-Nd1 In Diabetes Management.
Inventor includes Yuman.
The application for the patent was published on July 24, 2026, under issue no. 30/2026.
Abstract: A mitochondrial gene therapy specifically designed for the management of diabetes by targeting the MT-ND1 gene within pancreatic beta cells. This therapy utilizes a viral vector, selected from lentiviruses, adenoviruses, or adeno-associated viruses, engineered for precise mitochondrial targeting to deliver therapeutic genetic material directly to the mitochondria. The genetic material co...